Ally Bridge Group (NY) LLC
Source: SEC Form 13F · as of Mar 2026Ally Bridge Group (NY) LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $58.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$58.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for SOLENO THERAPEUTICS INC (SLNO)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| SLNOSOLENO THERAPEUTICS INC | 200,000 | $6.7M |
| OVIDOvid Therapeutics Inc. | 2,818,459 | $6.3M |
| CMPSCOMPASS Pathways plc | 1,045,000 | $5.8M |
| SLDBSolid Biosciences Inc. | 766,974 | $5.5M |
| PMNProMIS Neurosciences Inc. | 414,219 | $5.3M |
| CTMXCytomX Therapeutics, Inc. | 900,000 | $4.2M |
| IVAInventiva S.A. | 745,300 | $4.1M |
| CATXPerspective Therapeutics, Inc. | 926,557 | $3.9M |
| ABVXAbivax SA | 33,712 | $3.8M |
| ALMSALUMIS INC. | 166,959 | $3.7M |
| CAPRCAPRICOR THERAPEUTICS, INC. | 113,899 | $3.5M |
| WHWKWhitehawk Therapeutics, Inc. | 817,939 | $2.8M |
| ANTXAN2 Therapeutics, Inc. | 526,315 | $1.8M |
| RLMDRELMADA THERAPEUTICS, INC. | 210,525 | $1.5M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.